tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

China Reinsurance Secures Approval for New Independent Director, Strengthening Governance

Story Highlights
  • China Reinsurance announced the approval of Mr. Keung Yui Fai as an independent director.
  • The approval resolves compliance issues with board composition and enhances governance.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
China Reinsurance Secures Approval for New Independent Director, Strengthening Governance

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

China Reinsurance (Group) Corp. Class H ( (HK:1508) ) just unveiled an announcement.

China Reinsurance (Group) Corporation announced the approval of Mr. Keung Yui Fai as an independent non-executive director by the National Financial Regulatory Administration. This approval enables the company to comply with the Hong Kong Stock Exchange’s requirements for board composition, ensuring it has the requisite number of independent non-executive directors. The appointment also addresses previous regulatory compliance issues related to board composition and committee leadership, enhancing the company’s governance structure.

The most recent analyst rating on (HK:1508) stock is a Buy with a HK$2.10 price target. To see the full list of analyst forecasts on China Reinsurance (Group) Corp. Class H stock, see the HK:1508 Stock Forecast page.

More about China Reinsurance (Group) Corp. Class H

China Reinsurance (Group) Corporation is a major player in the reinsurance industry, offering a range of reinsurance products and services. The company focuses on providing comprehensive reinsurance solutions and operates within the People’s Republic of China, with its shares listed on the Hong Kong Stock Exchange.

Average Trading Volume: 41,975,558

Technical Sentiment Signal: Buy

Current Market Cap: HK$67.54B

For a thorough assessment of 1508 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1